Who is sponsoring NCT04456257?

NCT04456257 is sponsored by Mahidol University.

What drugs are being tested in NCT04456257?

Interventions in NCT04456257: fractional picosecond 1,064 nm laser.

What condition does NCT04456257 study?

NCT04456257 studies Striae Alba.

Is NCT04456257 still recruiting?

NCT04456257 is currently status unknown. Last updated 2 July 2020.

Last reviewed 2020-07-02 · How we verify

NCT04456257

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Efficacy of 1,064-nm Picosecond Laser With Microlens Array for the Treatment of Abdominal Striae Distensae

Status unknown NA Last updated 2 July 2020

What this trial tests

NA trial testing fractional picosecond 1,064 nm laser in Striae Alba in 12 participants. Status unknown.

Timeline

1 May 2020

Primary endpoint
30 December 2020

30 December 2020

Quick facts

Lead sponsor	Mahidol University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	12
Start date	1 May 2020
Primary completion	30 December 2020
Estimated completion	30 December 2020
Sites	1 location across Thailand

Drugs / interventions tested

fractional picosecond 1,064 nm laser

Conditions studied

Striae Alba — all drugs for Striae Alba →

Sponsor

Mahidol University

Who can join

Adults 18 to 60, female only, with Striae Alba. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to evaluate the efficacy and safety of a fractional 1,064 nm picosecond laser for the treatment of striae alba.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Mahidol University trials

Trials by the same sponsor.

NCT07568496 — Greater Occipital Nerve Block for Migraine With Medication Overuse Headache · NA · not yet recruiting
NCT07407400 — Lemborexant for Sleep and Delirium Prevention in Elderly ICU Patients · Phase 4 · not yet recruiting
NCT07378501 — Thai Version of the Pediatric Quality of Recovery Score (PedSQoR): Translation and Psychometric Validation Study · not yet recruiting
NCT07438301 — Septic Shock Hemodynamic Respond to Volume Resuscitation Versus Vasopressor Administration · not yet recruiting
NCT07390006 — Enabling Patient-Reported Outcomes Through Innovative Care - ACS (EPIC-ACS) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04456257 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mahidol University
Last refreshed: 2 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04456257.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing